NAPROXEN
RHEUMATOID ARTHRITIS·+3
CIPLA USA, INC.
Indication
Juvenile idiopathic arthritis
Juvenile idiopathic arthritis is a heterogeneous group of chronic, immune-mediated inflammatory arthropathies of unknown etiology that begin before the age of 16 and persist for at least six weeks. Read more about Juvenile idiopathic arthritis
871 drugs 326 manufacturers
Drugs that treat it
Common Juvenile idiopathic arthritis therapies.
NAPROXEN
GOUT·+8
CIPLA USA, INC.
MELOXICAM
RHEUMATOID ARTHRITIS·+2
STERLING-KNIGHT
CELECOXIB
NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·DYSMENORRHEA·+5
ALEMBIC PHARMAC
ASPIRIN EC (aspirin)
NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·MYOCARDIAL REINFARCTION PREVENTION·+11
MAGNO-HUMPHRIES
CELECOXIB
NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·DYSMENORRHEA·+5
CIPLA USA, INC.
DOUBLEDEX (dexamethasone sodium phosphate/PF)
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+60
ENOVACHEM MANUF
DEXAMETHASONE SODIUM PHOSPHATE
DISSEMINATED TUBERCULOSIS·+60
BD RX INC./APP
IBUPROFEN
NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·DYSMENORRHEA·+6
TARGET CORP
Filter & compare in the drug finder →Opens the drug finder with Juvenile idiopathic arthritis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonJuvenile idiopathic arthritis is a heterogeneous group of chronic, immune-mediated inflammatory arthropathies of unknown etiology that begin before the age of 16 and persist for at least six weeks.
Primarily affecting the musculoskeletal system of children and adolescents, the underlying pathology involves autoimmune or autoinflammatory synovitis that leads to joint swelling, pain, morning stiffness, and impaired range of motion.
The clinical spectrum ranges from oligoarticular and polyarticular involvement to subtypes characterized by enthesitis, psoriasis, or systemic features such as quotidian fevers, evanescent rashes, lymphadenopathy, and extra-articular complications like chronic uveitis.
Persistent disease activity can result in cartilage destruction, bone erosion, growth disturbances, and permanent joint disability.
- nih.gov
Juvenile idiopathic arthritis is a heterogeneous group of chronic, immune-mediated inflammatory arthropathies of unknown etiology that begin before the age of 16 and persist for at least six weeks Primarily affecting the musculoskeletal system of children and adolescents, the underlying pathology involves autoimmune or autoinflammatory synovitis that leads to joint swelling, pain, morning stiffness, and impaired range of motion The clinical spectrum ranges from oligoarticular and polyarticular i...
- nih.gov
Juvenile idiopathic arthritis is a heterogeneous group of chronic, immune-mediated inflammatory arthropathies of unknown etiology that begin before the age of 16 and persist for at least six weeks
- medlineplus.gov
Primarily affecting the musculoskeletal system of children and adolescents, the underlying pathology involves autoimmune or autoinflammatory synovitis that leads to joint swelling, pain, morning stiffness, and impaired range of motion Persistent disease activity can result in cartilage destruction, bone erosion, growth disturbances, and permanent joint disability
- medlineplus.gov
Primarily affecting the musculoskeletal system of children and adolescents, the underlying pathology involves autoimmune or autoinflammatory synovitis that leads to joint swelling, pain, morning stiffness, and impaired range of motion
- hss.edu
Persistent disease activity can result in cartilage destruction, bone erosion, growth disturbances, and permanent joint disability
Personalize your experience
Follow Juvenile idiopathic arthritis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.